| Mettl3-mediated mRNA m6A modification controls postnatal liver development by modulating the transcription factor Hnf4a Y Xu, Z Zhou, X Kang, L Pan, C Liu, X Liang, J Chu, S Dong, Y Li, Q Liu, ... Nature Communications 13 (1), 4555, 2022 | 27 | 2022 |
| The m6A methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis Y Li, X Kang, Z Zhou, L Pan, H Chen, X Liang, J Chu, S Dong, C Liu, S Yu, ... Molecular Therapy 30 (12), 3714-3728, 2022 | 24 | 2022 |
| Human Wharton's jelly-derived mesenchymal stem cells alleviate concanavalin A-induced fulminant hepatitis by repressing NF-κB signaling and glycolysis L Pan, C Liu, Q Liu, Y Li, C Du, X Kang, S Dong, Z Zhou, H Chen, X Liang, ... Stem Cell Research & Therapy 12, 1-14, 2021 | 12 | 2021 |
| Generation of a DAPK1 knockout first (conditional ready) human embryonic stem cell line (ZSSYe001-A) by CRISPR-Cas9 technology C Xu, Z Zhou, C Liu, X Kang, X Zhong, Q Zhang, Y Xu Stem Cell Research 43, 101693, 2020 | 3 | 2020 |
| m6A-mediated gluconeogenic enzyme PCK1 upregulation protects against hepatic ischemia-reperfusion injury S Yu, X Liu, Y Xu, L Pan, Y Zhang, Y Li, S Dong, D Tu, Y Sun, Y Zhang, ... Hepatology, 10.1097, 2023 | | 2023 |
| Targeting Cyclin‐Dependent Kinase 1 Induces Apoptosis and Cell Cycle Arrest of Activated Hepatic Stellate Cells X Kang, H Chen, Z Zhou, S Tu, B Cui, Y Li, S Dong, Q Zhang, Y Xu Advanced Biology, 2300403, 2023 | | 2023 |
